Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Startups channel feed
Guest column: The 3 big waves reshaping investment strategies in early-stage biotech
7 years ago
Financing
Biotech Voices
An autoimmune upstart turns PD-L1 around to blaze a new approach to diabetes, multiple sclerosis
7 years ago
Discovery
Ron DePinho raises seed cash for MD Anderson colleague's work on a 'Holy Grail molecule' in cancer, inflammation
7 years ago
Financing
With new $10.6B fund, Hillhouse Capital sets the stage for splashy Asia-focused biotech deals
7 years ago
Financing
China
Launch a new company, steer a $150M IPO and ink a big data collaboration — they call it Monday at Vivek Ramaswamy’s Roivant
7 years ago
Financing
Pharma
Mike Narachi gets a $19M shot at a new approach to gene therapy — and he has another big market in mind
7 years ago
Financing
Focusing on the tumor microenvironment, OncoResponse garners $40 million for the next stage of the R&D journey
7 years ago
Financing
MPM, Novartis lead a big launch round for Kazumi Shiosaki’s latest biotech startup coming out of Harvard
7 years ago
Financing
Third Rock woos top Roche scientist Sanjay Keswani to the helm of biotech startup Rheos Medicines
7 years ago
People
An elite team of young, transpacific scientists out of Harvard and MIT starts plowing next-gen cell therapy tech field
7 years ago
GSK spinout KaNDy raises $32M to fund a breakthrough shot at a women's health drug
7 years ago
Financing
Magic mushrooms might treat depression? Peter Thiel-backed Compass gets FDA OK to launch Phase IIb trials
7 years ago
One more gig: Steven Paul decides to extend a 35-year track record with one last shot at a big development program
7 years ago
People
Billionaire-backed Juvenescence spins out anti-aging, AI startup Napa Therapeutics
7 years ago
Financing
AI
Back to the beginning: Pfizer seeds discovery-stage neuro startup Magnolia (after axing its own brain R&D)
7 years ago
Financing
Tapping Chinese investors, Apexigen closes $73M for 8 trials in I/O
7 years ago
Financing
Third Rock's Ambys hauls $140M for liver disease, inking Takeda deal ahead of launch
7 years ago
Financing
NEA, 5AM back a $50M play to steer gene therapies to the clinic at Akouos — the latest startup in hearing
7 years ago
Financing
Stock scandals: Biotech incubator Fortress purchased brokerage firm to tout its own startups — Reuters
7 years ago
Genentech I/O chief Dan Chen heads to an upstart biotech looking to create a landmark advance on antibodies
7 years ago
People
The Google of CRISPR tech? Tech legends Tim Cook and Jeff Huber back Mammoth Biosciences
7 years ago
Financing
Faster, cheaper DNA sequencing gets Omniome $60M led by Chinese investors
7 years ago
Financing
Illumina's founding scientist launches software startup to track fast-mutating hospital bugs
7 years ago
People
Armed with $36M A round, Johns Hopkins spinout Neuraly heads to PhI Parkinson's trial
7 years ago
Financing
First page
Previous page
61
62
63
64
65
66
67
Next page
Last page